Group I and II mammalian PAKs have different modes of activation by Cdc42
Author:
Affiliation:
1. sGSK group, Astar Neuroscience Research Partnership Singapore 138673 Singapore
2. Institute of Medical Biology Singapore 138648
Publisher
EMBO
Subject
Genetics,Molecular Biology,Biochemistry
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1038/embor.2012.75
Reference31 articles.
1. Structure of PAK1 in an Autoinhibited Conformation Reveals a Multistage Activation Switch
2. A Conserved Negative Regulatory Region in αPAK: Inhibition of PAK Kinases Reveals Their Morphological Roles Downstream of Cdc42 and Rac1
3. PAK and other Rho-associated kinases – effectors with surprisingly diverse mechanisms of regulation
4. PAK4, a novel effector for Cdc42Hs, is implicated in the reorganization of the actin cytoskeleton and in the formation of filopodia
5. PAK5, a New Brain-Specific Kinase, Promotes Neurite Outgrowth in N1E-115 Cells
Cited by 95 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. PAK6-mediated phosphorylation of PPP2R2C regulates LRRK2-PP2A complex formation;Frontiers in Molecular Neuroscience;2023-12-18
2. PAK4 inhibition significantly potentiates Gemcitabine activity in PDAC cells via inhibition of Wnt/β-catenin, p-ERK/MAPK and p-AKT/PI3K pathways;Biochemistry and Biophysics Reports;2023-09
3. Azeliragon inhibits PAK1 and enhances the therapeutic efficacy of AKT inhibitors in pancreatic cancer;European Journal of Pharmacology;2023-06
4. Expression Patterns of PAK4 and PHF8 Are Associated with the Survival of Gallbladder Carcinoma Patients;Diagnostics;2023-03-17
5. PAK1 c.1409 T > a (p. Leu470Gln) de novo variant affects the protein kinase domain, leading to epilepsy, macrocephaly, spastic quadriplegia, and hydrocephalus: Case report and review of the literature;American Journal of Medical Genetics Part A;2023-03-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3